Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AORT

Artivion (AORT)

Artivion Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:AORT
DataHoraFonteTítuloCódigoCompanhia
03/06/202409:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
30/05/202417:12Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:AORTArtivion Inc
17/05/202417:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:AORTArtivion Inc
10/05/202419:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AORTArtivion Inc
07/05/202413:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AORTArtivion Inc
06/05/202417:05PR Newswire (US)Artivion Reports First Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
29/04/202409:05PR Newswire (US)Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual MeetingNYSE:AORTArtivion Inc
22/04/202417:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsNYSE:AORTArtivion Inc
01/04/202417:10PR Newswire (US)Artivion to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:AORTArtivion Inc
11/03/202418:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AORTArtivion Inc
06/03/202418:10PR Newswire (US)Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:AORTArtivion Inc
15/02/202418:05PR Newswire (US)Artivion Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:AORTArtivion Inc
14/02/202408:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:AORTArtivion Inc
01/02/202418:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial ResultsNYSE:AORTArtivion Inc
30/01/202422:12Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
29/01/202410:25PR Newswire (US)Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual MeetingNYSE:AORTArtivion Inc
18/01/202418:05PR Newswire (US)Artivion Obtains $350 Million in Senior Secured Credit FacilitiesNYSE:AORTArtivion Inc
08/12/202311:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:AORTArtivion Inc
06/12/202318:15PR Newswire (US)Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial OfficerNYSE:AORTArtivion Inc
09/11/202310:25PR Newswire (US)Artivion Announces Completion of Enrollment in PERSEVERE TrialNYSE:AORTArtivion Inc
08/11/202318:05PR Newswire (US)Artivion to Participate in Upcoming Investor ConferencesNYSE:AORTArtivion Inc
02/11/202317:05PR Newswire (US)Artivion Reports Third Quarter 2023 Financial ResultsNYSE:AORTArtivion Inc
19/10/202317:10PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial ResultsNYSE:AORTArtivion Inc
05/10/202317:15PR Newswire (US)Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose WarfarinNYSE:AORTArtivion Inc
05/10/202317:05PR Newswire (US)Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual MeetingNYSE:AORTArtivion Inc
26/09/202309:25PR Newswire (US)Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance ConferenceNYSE:AORTArtivion Inc
14/09/202309:05PR Newswire (US)Artivion to Present at the Gilmartin Group Emerging Growth Company ShowcaseNYSE:AORTArtivion Inc
03/08/202317:05PR Newswire (US)Artivion Reports Second Quarter 2023 Financial ResultsNYSE:AORTArtivion Inc
20/07/202309:25PR Newswire (US)Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial ResultsNYSE:AORTArtivion Inc
09/06/202317:28Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:AORTArtivion Inc
 Apresentando as notícias mais relevantes sobre:NYSE:AORT